Symbicort® (budesonide/formoterol) Asthma
This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
Asthma ICS/LABAs and Symbicort®
Symbicort® tolerability profile1-3
Since Symbicort® contains both budesonide and formoterol, the same pattern of undesirable effects as reported for these substances may occur.1-3
The most common drug-related adverse reactions are pharmacologically predictable side effects of β2-adrenoceptor agonist therapy, such as tremor and palpitations; these tend to be mild and usually disappear within a few days of treatment.1-3
*Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100). Only very common, common and uncommon side effects are presented.Please refer to the SmPC for the full list of adverse events.1-3